![Biodexa Pharmaceuticals plc American Depositary Shs](/_next/image?url=https%3A%2F%2Fcdn.itspluto.com%2Fstock%2Fbdrx.png&w=48&q=75)
Biodexa Pharmaceuticals plc American Depositary Shs
Compare this stock
BDRX Stock Report Card
$
36%
Performance
Score:
10/100
BDRX returned -98.01% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.
Volatility
Score:
71/100
BDRX has had a higher than average amount of volatility over the last 12 months giving it a score of 71 of 100.
Biodexa Pharmaceuticals plc American Depositary Shs Summary
Nasdaq / BDRX
Healthcare
Biotechnology
Biodexa Pharmaceuticals Plc, a drug delivery technology company, focuses on the bio-delivery and biodistribution of medicines in Belgium and internationally. The company is developing MTX110, a direct delivery treatment for diffuse intrinsic pontine glioma, medulloblastomas, and glioblastoma multiforme; MTD211, a long-acting formulation of brexpiprazole for the treatment of schizophrenia and adjunctive treatment of major depressive disorder; and MTX223, a long-acting injectable formulations of biologic products, such as mAbs or other high molecular weight proteins. It also offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release drug delivery; MidaSolve, an oligosaccharide nanotechnology used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors; and MidaCore, a gold nanoparticle used for targeting sites of disease by using chemotherapeutic agents or immunotherapeutic agents. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.
Power up your portfolio
Build a portfolio of your favorite stocks
Pluto makes it easy to build investing strategies and automate your portfolio
Checkout Similar Companies
BDRX scored poorly on our reportcard. Here are some similar companies and how they performed.